Friday, October 3, 2025
15 C
Srinagar

Natco’s marketing partner Alvogen receives USFDA approval for chest pain tablets

Mumbai,  : Pharma Major Natco Pharma Limited said that its marketing partner Alvogen has received the final approval of Abbreviated New Drug Application (ANDA) from the USFDA for chest pain tablets.
The company has received the final approval of Abbreviated New Drug Application (ANDA) from the United States Food and Drug Administration (FDA) for Nitroglycerin Sublingual Tablets USP, 0.3 mg, 0.4 mg, and 0.6 mg, Natco Pharma said in a BSE filing.
Pfizer Pharmaceuticals Ltd markets this drug under its brand Nitrostat Sublingual Tablets in the same strengths mentioned above.
As per IQVIA data, Nitroglycerin Sublingual Tablets had total annual sales of around USD 77.3 million in the US market, for the year ending 2018.
(UNI)

Hot this week

Srinagar Municipal Corporation Concludes “Sewa Parv 2025” with Grand Culmination Event at Jhelum River Front Rajbagh

AM News Network Srinagar,Oct 2: The Srinagar Municipal Corporation (SMC)...

Bar Association Kargil Suspends Judicial Work for Six Days in Protest Over Leh Killings

Kargil, Oct 1,: The Bar Association Kargil has announced...

Twenty-Six Granted Bail in Leh Violence Case, Scores Still in Jail

Leh, Oct 2,: A court in Leh has granted...

Leh Apex Body Rejects Magisterial Probe, Demands Judicial Inquiry, Release of Detainees

 Leh, Oct 2,: The Leh Apex Body (LAB) has...

Uphold Gandhian principles, promote Swadeshi: LG Sinha to youth

Says Mahatma Gandhi saw ray of hope in J&K,...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img